{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T16:21:26Z","timestamp":1787934086836,"version":"build-2784847793"},"reference-count":156,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","award":["CA22125"],"award-info":[{"award-number":["CA22125"]}],"id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.bbcan.2025.189457","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T22:08:40Z","timestamp":1758578920000},"page":"189457","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cancer-associated thrombosis in cholangiocarcinoma: Exploring a phenotype of tumor aggressiveness"],"prefix":"10.1016","volume":"1880","author":[{"given":"Luca","family":"Fabris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahima","family":"Fri\u00f3n-Herrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Cadamuro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Campello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Simioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbcan.2025.189457_bb0005","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: the next horizon in mechanisms and management","volume":"17","author":"Banales","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbcan.2025.189457_bb0010","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.jhep.2019.07.024","article-title":"Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma","volume":"71","author":"Khan","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbcan.2025.189457_bb0015","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/14728222.2020.1733528","article-title":"Cholangiocarcinoma: novel therapeutic targets HHS public access","volume":"24","author":"Sato","year":"2020","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.bbcan.2025.189457_bb0020","doi-asserted-by":"crossref","first-page":"S178","DOI":"10.21037\/cdt.2017.11.02","article-title":"Thrombosis in cancer patients: etiology, incidence, and management","volume":"7","author":"Sheth","year":"2017","journal-title":"Cardiovasc. Diagn Ther."},{"key":"10.1016\/j.bbcan.2025.189457_bb0025","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1007\/s00432-021-03794-1","article-title":"Predictors for thromboembolism in patients with cholangiocarcinoma","volume":"148","author":"Pfrepper","year":"2022","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2025.189457_bb0030","first-page":"10","article-title":"Cancer-associated thrombosis in cirrhotic patients with hepatocellular carcinoma","author":"Zanetto","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2025.189457_bb0035","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3390\/cancers11020158","article-title":"The history of Armand trousseau and Cancer-associated thrombosis","volume":"11","author":"Metharom","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2025.189457_bb0040","doi-asserted-by":"crossref","first-page":"566","DOI":"10.3390\/cancers12030566","article-title":"Potential mechanisms of cancer-related hypercoagulability","volume":"12","author":"Nasser","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2025.189457_bb0045","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/HS9.0000000000000239","article-title":"Mechanisms of cancer-associated thrombosis","volume":"3","author":"Mege","year":"2019","journal-title":"HemaSphere"},{"key":"10.1016\/j.bbcan.2025.189457_bb0050","first-page":"8","article-title":"Cancer-associated venous thromboembolism","author":"Khorana","year":"2022","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.bbcan.2025.189457_bb0055","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1007\/s11239-024-02963-6","article-title":"Superficial vein thrombosis and its relationship with malignancies: a prospective observational study","volume":"57","author":"D\u00edez-Vidal","year":"2024","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.bbcan.2025.189457_bb0060","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.jtha.2024.01.019","article-title":"Natural history of Cancer-associated splanchnic vein thrombosis","volume":"22","author":"Shang","year":"2024","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.bbcan.2025.189457_bb0065","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/jth.14210","article-title":"Cerebral venous sinus thrombosis","volume":"16","author":"Capecchi","year":"2018","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.bbcan.2025.189457_bb0070","doi-asserted-by":"crossref","first-page":"e23322","DOI":"10.1200\/JCO.2024.42.16_suppl.e23322","article-title":"In-hospital outcomes of patients with lung cancer with and without superior vena cava thrombosis: a nationwide analysis","volume":"42","author":"Sanghvi","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2025.189457_bb0075","first-page":"247","article-title":"Renal cell carcinoma with IVC thrombi; current concepts and future perspectives","volume":"2","author":"Nouh","year":"2008","journal-title":"Clin. Med. Oncol."},{"key":"10.1016\/j.bbcan.2025.189457_bb0080","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1182\/asheducation-2016.1.413","article-title":"The post-thrombotic syndrome","volume":"2016","author":"Kahn","year":"2016","journal-title":"Hematology Am. Soc. Hematol. Educ. Program"},{"key":"10.1016\/j.bbcan.2025.189457_bb0085","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jacc.2014.04.063","article-title":"Paradoxical Embolism","volume":"64","author":"Windecker","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbcan.2025.189457_bb0090","doi-asserted-by":"crossref","first-page":"470.e9","DOI":"10.1016\/j.avsg.2019.05.038","article-title":"Intrahepatic cholangiocarcinoma associated paradoxical peripheral embolism and a submassive pulmonary embolism","volume":"61","author":"Zhang","year":"2019","journal-title":"Ann. Vasc. Surg."},{"key":"10.1016\/j.bbcan.2025.189457_bb0095","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3121\/cmr.2009.866","article-title":"Virchow\u2019s contribution to the understanding of thrombosis and cellular biology","volume":"8","author":"Kumar","year":"2010","journal-title":"Clin. Med. Res."},{"key":"10.1016\/j.bbcan.2025.189457_bb0100","doi-asserted-by":"crossref","first-page":"640S","DOI":"10.1378\/chest.102.6_Supplement.640S","article-title":"Pathogenesis of venous thrombosis","volume":"102","author":"Mammen","year":"1992","journal-title":"Chest"},{"key":"10.1016\/j.bbcan.2025.189457_bb0105","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1182\/blood.2020007338","article-title":"Venous thromboembolism in cancer patients: a population-based cohort study","volume":"137","author":"Mulder","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.bbcan.2025.189457_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001275","article-title":"Risk of venous thromboembolism in patients with cancer: a systematic review and meta-analysis","volume":"9","author":"Horsted","year":"2012","journal-title":"PLoS Med."},{"key":"10.1016\/j.bbcan.2025.189457_bb0115","article-title":"Venous thromboembolism in patients with brain Cancer: Focus on prophylaxis and management","volume":"12","author":"Kabashneh","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.bbcan.2025.189457_bb0120","first-page":"267","article-title":"Thromboembolism in gastrointestinal cancers","volume":"2","author":"Tetzlaff","year":"2008","journal-title":"Gastrointest. Cancer Res."},{"issue":"Suppl. 1","key":"10.1016\/j.bbcan.2025.189457_bb0125","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/sj.bjc.6605599","article-title":"Epidemiology and pathophysiology of cancer-associated thrombosis","volume":"102","author":"Noble","year":"2010","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2025.189457_bb0130","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.thromres.2005.10.015","article-title":"Chemotherapy-induced thrombosis","volume":"118","author":"Haddad","year":"2006","journal-title":"Thromb. Res."},{"key":"10.1016\/j.bbcan.2025.189457_bb0135","first-page":"35","article-title":"Mechanisms of thrombosis in pancreatic ductal adenocarcinoma","author":"Campello","year":"2022","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"10.1016\/j.bbcan.2025.189457_bb0140","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1182\/bloodadvances.2021005590","article-title":"The incidence of cancer-associated thrombosis is increasing over time","volume":"6","author":"Mahajan","year":"2025","journal-title":"Blood Adv."},{"key":"10.1016\/j.bbcan.2025.189457_bb0145","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.ejca.2012.10.021","article-title":"Incidence of venous thromboembolism in patients with cancer \u2013 a cohort study using linked United Kingdom databases","volume":"49","author":"Walker","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bbcan.2025.189457_bb0150","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1538-7836.2006.01804.x","article-title":"Incidence of venous thrombosis in a large cohort of 66329 cancer patients: results of a record linkage study","volume":"4","author":"Blom","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.bbcan.2025.189457_bb0155","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1161\/ATVBAHA.123.318779","article-title":"ATVB IN FOCUS: Thromboinflammation and infection updates in the incidence, pathogenesis, and Management of Cancer and Venous Thromboembolism","volume":"43","author":"Editors","year":"2023","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbcan.2025.189457_bb0160","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3390\/cancers10100380","article-title":"Cancer-associated thrombosis: an overview of mechanisms, risk factors, and treatment","volume":"10","author":"Razak","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2025.189457_bb0165","first-page":"9049","article-title":"Incidence and significance of thromboembolic events (TE) in patients with gastrointestinal (GI) and non-GI malignancies on systemic cytotoxic therapy","volume":"25","author":"Asmis","year":"2007"},{"key":"10.1016\/j.bbcan.2025.189457_bb0170","first-page":"444","article-title":"Venous thromboembolism in patients with cholangiocarcinoma: Focus on risk factors and impact on survival","volume":"24","author":"Jeon","year":"2012","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbcan.2025.189457_bb0175","doi-asserted-by":"crossref","first-page":"165","DOI":"10.5009\/gnl220477","article-title":"Clinical significance of venous thromboembolism in patients with advanced cholangiocarcinoma","volume":"18","author":"Kim","year":"2024","journal-title":"Gut Liver"},{"key":"10.1016\/j.bbcan.2025.189457_bb0180","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3121\/cmr.2015.1304","article-title":"Trousseau\u2019s syndrome in cholangiocarcinoma: the risk of making the diagnosis","volume":"14","author":"Blum","year":"2025","journal-title":"Clin. Med. Res."},{"key":"10.1016\/j.bbcan.2025.189457_bb0185","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/MBC.0000000000000672","article-title":"Prediction of thromboembolic complications after liver resection for cholangiocarcinoma: is there a place for thromboelastometry?","volume":"29","author":"Blasi","year":"2018","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.bbcan.2025.189457_bb0190","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1111\/jgh.13309","article-title":"Outcomes of intrahepatic cholangiocarcinoma with portal vein tumor thrombus following hepatic resection","volume":"31","author":"De","year":"2016","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbcan.2025.189457_bb0195","doi-asserted-by":"crossref","first-page":"469","DOI":"10.5582\/bst.2017.01080","article-title":"Coagulopathy associated with poor prognosis in intrahepatic cholangiocarcinoma patients after curative resection","volume":"11","author":"Wang","year":"2017","journal-title":"Biosci. Trends"},{"key":"10.1016\/j.bbcan.2025.189457_bb0200","doi-asserted-by":"crossref","first-page":"3648","DOI":"10.1016\/j.asjsur.2023.02.015","article-title":"Venous thromboembolism in patients undergoing distal cholangiocarcinoma surgery: prevalence, risk factors, and outcomes","volume":"46","author":"Chen","year":"2023","journal-title":"Asian J. Surg."},{"key":"10.1016\/j.bbcan.2025.189457_bb0205","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.3390\/ijms24032262","article-title":"Shedding light on the pathogenesis of splanchnic vein thrombosis","volume":"24","author":"Camerlo","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2025.189457_bb0210","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1080\/08998280.2021.1930968","article-title":"Liver infarct masquerading as intrahepatic cholangiocarcinoma","volume":"34","author":"Fariduddin","year":"2021","journal-title":"Proc. (Baylor Univ. Med. Cent.)"},{"key":"10.1016\/j.bbcan.2025.189457_bb0215","first-page":"837","article-title":"Allograft inflow-concern in liver transplantation after intraoperative radiotherapy for cholangiocarcinoma","volume":"109","author":"Lupa\u015fcu","year":"2014","journal-title":"Chir"},{"key":"10.1016\/j.bbcan.2025.189457_bb0220","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/jth.15214","article-title":"Clinical history of cancer-associated splanchnic vein thrombosis","volume":"19","author":"Valeriani","year":"2021","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.bbcan.2025.189457_bb0225","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2147\/CMAR.S47094","article-title":"Cancer-associated thrombosis: clinical presentation and survival","volume":"5","author":"Amer","year":"2013","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.bbcan.2025.189457_bb0230","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jviscsurg.2023.06.005","article-title":"Early portal vein thrombosis after hepatectomy for perihilar cholangiocarcinoma: incidence, risk factors, and management","volume":"160","author":"Lemaire","year":"2023","journal-title":"J. Visc. Surg."},{"key":"10.1016\/j.bbcan.2025.189457_bb0235","series-title":"Overcome Drug Resistance in Cholangiocarcinoma: New Insight Into Mechanisms and Refining the Preclinical Experiment Models","author":"Zheng","year":"2025"},{"key":"10.1016\/j.bbcan.2025.189457_bb0240","doi-asserted-by":"crossref","first-page":"450","DOI":"10.7150\/jca.68264","article-title":"The new insight of treatment in cholangiocarcinoma","volume":"13","author":"Li","year":"2022","journal-title":"J. Cancer"},{"key":"10.1016\/j.bbcan.2025.189457_bb0245","doi-asserted-by":"crossref","DOI":"10.1177\/1076029620954282","article-title":"Cancer-associated thrombosis: risk factors, molecular mechanisms, future management","volume":"26","author":"Hamza","year":"2020","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"10.1016\/j.bbcan.2025.189457_bb0250","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.jhep.2021.12.010","article-title":"Cholangiocarcinoma landscape in Europe: diagnostic, prognostic and therapeutic insights from the ENSCCA registry","volume":"76","author":"Izquierdo-Sanchez","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbcan.2025.189457_bb0255","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.1200\/JCO.2011.35.5669","article-title":"High incidence of thromboembolic events in patients treated with cisplatin-based chemotherapy: a large retrospective analysis","volume":"29","author":"Moore","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2025.189457_bb0260","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.2147\/IJGM.S320492","article-title":"Cancer-associated thrombosis: a clinical scoping review of the risk assessment models across solid Tumours and Haematological malignancies","volume":"14","author":"Mosaad","year":"2021","journal-title":"Int. J. Gen. Med."},{"key":"10.1016\/j.bbcan.2025.189457_bb0265","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1016\/S0049-3848(20)30397-2","article-title":"Overview of risk assessment models for venous thromboembolism in ambulatory patients with cancer","volume":"191","author":"Gerotziafas","year":"2020","journal-title":"Thromb. Res."},{"key":"10.1016\/j.bbcan.2025.189457_bb0270","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1159\/000508271","article-title":"Evaluation of biomarkers for the prediction of venous thromboembolism in ambulatory Cancer patients","volume":"43","author":"Schorling","year":"2020","journal-title":"Oncol. Res. Treat."},{"key":"10.1016\/j.bbcan.2025.189457_bb0275","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.12659\/MSM.895040","article-title":"Diagnostic accuracy of serum CA19-9 in patients with cholangiocarcinoma: a systematic review and Meta-analysis","volume":"21","author":"Liang","year":"2015","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.bbcan.2025.189457_bb0280","first-page":"11","article-title":"C-reactive protein and Cancer-diagnostic and therapeutic insights","author":"Hart","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2025.189457_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijscr.2022.106904","article-title":"Recurrent acute portal vein thrombosis with severe abdominal infection after right hemihepatectomy in a patient with perihilar cholangiocarcinoma: a case report and literature review","volume":"93","author":"Deng","year":"2022","journal-title":"Int. J. Surg. Case Rep."},{"key":"10.1016\/j.bbcan.2025.189457_bb0290","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/ccr3.187","article-title":"Upper extremity deep vein thrombosis: a complication of an indwelling peripherally inserted central venous catheter","volume":"3","author":"Carr","year":"2015","journal-title":"Clin. Case Reports"},{"key":"10.1016\/j.bbcan.2025.189457_bb0295","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1182\/blood-2007-10-116327","article-title":"Development and validation of a predictive model for chemotherapy-associated thrombosis","volume":"111","author":"Khorana","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bbcan.2025.189457_bb0300","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/j.jtha.2023.03.037","article-title":"Utility of the Khorana and the new-Vienna CATS prediction scores in cancer patients of the HYPERCAN cohort","volume":"21","author":"Verzeroli","year":"2023","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.bbcan.2025.189457_bb0305","doi-asserted-by":"crossref","first-page":"e289","DOI":"10.1016\/S2352-3026(18)30063-2","article-title":"A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts","volume":"5","author":"Pabinger","year":"2018","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.bbcan.2025.189457_bb0310","first-page":"3755","article-title":"Development of a clinical prediction tool for cancer-associated venous thromboembolism (CAT): the MD Anderson Cancer Center CAT model","volume":"28","author":"Rojas-Hernandez","year":"2020","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.bbcan.2025.189457_bb0315","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1634\/theoncologist.2016-0414","article-title":"A predictive score for thrombosis associated with breast, colorectal, lung, or ovarian Cancer: the prospective COMPASS\u2013Cancer-associated thrombosis study","volume":"22","author":"Gerotziafas","year":"2017","journal-title":"Oncologist"},{"key":"10.1016\/j.bbcan.2025.189457_bb0320","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.3324\/haematol.2017.169060","article-title":"Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort study","volume":"102","author":"van Es","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.bbcan.2025.189457_bb0325","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11239-019-01845-6","article-title":"Long-term performance of risk scores for venous thromboembolism in ambulatory cancer patients","volume":"48","author":"Di Nisio","year":"2019","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.bbcan.2025.189457_bb0330","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1200\/JCO.2014.55.1481","article-title":"Efficacy of prophylactic low-molecular weight heparin for ambulatory patients with advanced pancreatic Cancer: outcomes from the CONKO-004 trial","volume":"33","author":"Pelzer","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2025.189457_bb0335","first-page":"118","article-title":"ARTICLE multivariable clinical-genetic risk model for predicting venous thromboembolic events in patients with cancer","author":"Mart\u00edn","year":"2018","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2025.189457_bb0340","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1634\/theoncologist.2016-0246","article-title":"Preventing venous thromboembolism in ambulatory Cancer patients: the ONKOTEV study","volume":"22","author":"Cella","year":"2017","journal-title":"Oncologist"},{"key":"10.1016\/j.bbcan.2025.189457_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2023.189053","article-title":"Cancer-associated thrombosis: what about microRNAs targeting the tissue factor coagulation pathway?","volume":"1879","author":"Tavares","year":"2024","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.bbcan.2025.189457_bb0350","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jjcc.2018.02.011","article-title":"Mechanism and management of cancer-associated thrombosis","volume":"72","author":"Mukai","year":"2018","journal-title":"J. Cardiol."},{"key":"10.1016\/j.bbcan.2025.189457_bb0355","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1055\/s-0043-1777304","article-title":"Cellular components contributing to the development of venous thrombosis in patients with pancreatic Cancer","volume":"50","author":"Willems","year":"2024","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.bbcan.2025.189457_bb0360","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/ijc.28997","article-title":"Inhibition of platelet activation prevents the P-selectin and integrin-dependent accumulation of cancer cell microparticles and reduces tumor growth and metastasis in vivo","volume":"136","author":"Mezouar","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2025.189457_bb0365","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1186\/1471-2407-11-357","article-title":"Downregulation of TFPI in breast cancer cells induces tyrosine phosphorylation signaling and increases metastatic growth by stimulating cell motility","volume":"11","author":"Stavik","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbcan.2025.189457_bb0370","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jhep.2018.12.004","article-title":"Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma","volume":"70","author":"Cadamuro","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbcan.2025.189457_bb0375","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1038\/s41416-022-01968-3","article-title":"Tissue factor in cancer-associated thromboembolism: possible mechanisms and clinical applications","volume":"127","author":"Koizume","year":"2022","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2025.189457_bb0380","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1373\/clinchem.2009.123695","article-title":"Increased tissue factor expression is associated with reduced survival in non-small cell lung cancer and with mutations of TP53 and PTEN","volume":"55","author":"Regina","year":"2009","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bbcan.2025.189457_bb0385","doi-asserted-by":"crossref","first-page":"10643","DOI":"10.1158\/0008-5472.CAN-06-2350","article-title":"Oncogenes, trousseau syndrome, and Cancer-related changes in the Coagulome of mice and humans","volume":"66","author":"Rak","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2025.189457_bb0390","doi-asserted-by":"crossref","first-page":"20220652","DOI":"10.1515\/biol-2022-0652","article-title":"Genetic alterations of KRAS and TP53 in intrahepatic cholangiocarcinoma associated with poor prognosis","volume":"18","author":"Peng","year":"2023","journal-title":"Open Life Sci."},{"key":"10.1016\/j.bbcan.2025.189457_bb0395","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1182\/blood-2011-06-317685","article-title":"The relationship between tissue factor and cancer progression: insights from bench and bedside","volume":"119","author":"Van Den Berg","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbcan.2025.189457_bb0400","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1172\/JCI117202","article-title":"Endothelial cells stimulated with tumor necrosis factor-alpha express varying amounts of tissue factor resulting in inhomogenous fibrin deposition in a native blood flow system. Effects of thrombin inhibitors","volume":"93","author":"Kirchhofer","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2025.189457_bb0405","article-title":"Systematic study of tissue factor expression in solid tumors","volume":"6","author":"de Bono","year":"2023","journal-title":"Cancer Rep."},{"key":"10.1016\/j.bbcan.2025.189457_bb0410","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1159\/000363689","article-title":"Trousseau\u2019s syndrome caused by intrahepatic cholangiocarcinoma: an autopsy case report and literature review","volume":"7","author":"Yuri","year":"2014","journal-title":"Case Rep. Oncol."},{"key":"10.1016\/j.bbcan.2025.189457_bb0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.102310","article-title":"Tissue factor pathway-related biomarkers in liver cancer: activated factor VII\u2013antithrombin complex and tissue factor mRNA levels are associated with mortality","volume":"8","author":"Martinelli","year":"2024","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"10.1016\/j.bbcan.2025.189457_bb0420","doi-asserted-by":"crossref","first-page":"12772","DOI":"10.3390\/ijms232112772","article-title":"Platelets and their role in hemostasis and thrombosis\u2014from physiology to pathophysiology and therapeutic implications","volume":"23","author":"Scridon","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2025.189457_bb0425","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1161\/CIRCRESAHA.122.321861","article-title":"Mechanism of tumor-platelet Communications in Cancer","volume":"132","author":"Dudiki","year":"2023","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbcan.2025.189457_bb0430","first-page":"8","article-title":"Cholangiocarcinoma cell induced platelet aggregation via activation of thrombin and cyclooxygenase","volume":"61","author":"Pravit","year":"2009","journal-title":"Siriraj Med. J."},{"key":"10.1016\/j.bbcan.2025.189457_bb0435","first-page":"3577","article-title":"Platelet-derived PDGF promotes the invasion and metastasis of cholangiocarcinoma by upregulating MMP2\/MMP9 expression and inducing EMT via the p38\/MAPK signalling pathway","volume":"12","author":"Pan","year":"2020","journal-title":"Am. J. Transl. Res."},{"issue":"Suppl. 1","key":"10.1016\/j.bbcan.2025.189457_bb0440","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/j.thromres.2018.01.020","article-title":"The role of podoplanin in cancer-associated thrombosis","volume":"164","author":"Mir Seyed Nazari","year":"2018","journal-title":"Thromb. Res."},{"key":"10.1016\/j.bbcan.2025.189457_bb0445","doi-asserted-by":"crossref","first-page":"1118843","DOI":"10.3389\/fneur.2023.1118843","article-title":"Podoplanin: a potential therapeutic target for thrombotic diseases","volume":"14","author":"Huang","year":"2023","journal-title":"Front. Neurol."},{"key":"10.1016\/j.bbcan.2025.189457_bb0450","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1182\/blood-2016-06-720714","article-title":"Podoplanin expression in primary brain tumors induces platelet aggregation and increases risk of venous thromboembolism","volume":"129","author":"Riedl","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.bbcan.2025.189457_bb0455","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/jth.15544","article-title":"Podoplanin promotes tumor growth, platelet aggregation, and venous thrombosis in murine models of ovarian cancer","volume":"20","author":"Sasano","year":"2022","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.bbcan.2025.189457_bb0460","first-page":"137","article-title":"Podoplanin is an important stromal prognostic marker in perihilar cholangiocarcinoma","volume":"15","author":"Obulkasim","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbcan.2025.189457_bb0465","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.bbadis.2017.07.024","article-title":"Role of inflammation and proinflammatory cytokines in cholangiocyte pathophysiology","volume":"1864","author":"Pinto","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.bbcan.2025.189457_bb0470","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.beha.2008.12.009","article-title":"Procoagulant mechanisms in tumour cells","volume":"22","author":"Falanga","year":"2009","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"10.1016\/j.bbcan.2025.189457_bb0475","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3389\/fped.2018.00142","article-title":"The role of inflammation in venous thromboembolism","volume":"6","author":"Branchford","year":"2018","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.bbcan.2025.189457_bb0480","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/stem.5530120405","article-title":"Effects of interleukin 6 on megakaryocytes and on canine platelet function","volume":"12","author":"Burstein","year":"1994","journal-title":"Stem Cells"},{"key":"10.1016\/j.bbcan.2025.189457_bb0485","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1089\/107999099313604","article-title":"Elevated serum thrombopoietin and interleukin-6 concentrations in thrombocytosis associated with inflammatory bowel disease","volume":"19","author":"Heits","year":"1999","journal-title":"J. Interf. Cytokine Res."},{"key":"10.1016\/j.bbcan.2025.189457_bb0490","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00281-011-0282-8","article-title":"Thrombomodulin and its role in inflammation","volume":"34","author":"Conway","year":"2012","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.bbcan.2025.189457_bb0495","doi-asserted-by":"crossref","first-page":"5196","DOI":"10.4049\/jimmunol.1300354","article-title":"Lipopolysaccharide stimulates platelets through an IL-1\u03b2 autocrine loop","volume":"191","author":"Brown","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbcan.2025.189457_bb0500","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1182\/blood.V90.9.3595","article-title":"Fibrin regulation of interleukin-8 gene expression in human vascular endothelial cells","volume":"90","author":"Qi","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bbcan.2025.189457_bb0505","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/00000658-199803000-00012","article-title":"Marked elevation of serum interleukin-6 in patients with cholangiocarcinoma: validation of utility as a clinical marker","volume":"227","author":"Goydos","year":"1998","journal-title":"Ann. Surg."},{"key":"10.1016\/j.bbcan.2025.189457_bb0510","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2019.00293","article-title":"Inflammation and progression of cholangiocarcinoma: role of Angiogenic and Lymphangiogenic mechanisms","volume":"6","author":"Roy","year":"2019","journal-title":"Front. Med."},{"key":"10.1016\/j.bbcan.2025.189457_bb0515","doi-asserted-by":"crossref","first-page":"846","DOI":"10.3390\/cells12060846","article-title":"Heterogeneity of cholangiocarcinoma immune biology","volume":"12","author":"Vita","year":"2023","journal-title":"Cells"},{"issue":"Suppl. 2","key":"10.1016\/j.bbcan.2025.189457_bb0520","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1097\/00005344-199500252-00004","article-title":"Cytokines and thrombosis","volume":"25","author":"Dosquet","year":"1995","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.bbcan.2025.189457_bb0525","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.786387","article-title":"The emerging role of neutrophil extracellular traps in arterial, venous and Cancer-associated thrombosis","volume":"8","author":"Zhou","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.bbcan.2025.189457_bb0530","doi-asserted-by":"crossref","first-page":"e277","DOI":"10.3324\/haematol.2015.140632","article-title":"Histones stimulate von Willebrand factor release in vitro and in vivo","volume":"101","author":"Lam","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.bbcan.2025.189457_bb0535","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/jth.13951","article-title":"Citrullinated histone H3, a biomarker of neutrophil extracellular trap formation, predicts the risk of venous thromboembolism in cancer patients","volume":"16","author":"Mauracher","year":"2018","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.bbcan.2025.189457_bb0540","first-page":"15","article-title":"Circulating and tumor-associated neutrophils in the era of immune checkpoint inhibitors: dynamics, phenotypes, metabolism, and functions","author":"Gibellini","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2025.189457_bb0545","first-page":"4","article-title":"Primary tumors induce neutrophil extracellular traps with targetable metastasis-promoting effects. JCI","author":"Rayes","year":"2019","journal-title":"Insight"},{"key":"10.1016\/j.bbcan.2025.189457_bb0550","first-page":"405","article-title":"NF-\u03baB and neutrophil extracellular traps cooperate to promote breast cancer progression and metastasis","author":"Zhu","year":"2021","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bbcan.2025.189457_bb0555","first-page":"17","article-title":"Role of neutrophil extracellular traps in regulation of lung cancer invasion and metastasis: structural insights from a computational model","author":"Lee","year":"2021","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.bbcan.2025.189457_bb0560","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1084\/jem.20181170","article-title":"Neutrophils facilitate ovarian cancer premetastatic niche formation in the omentum","volume":"216","author":"Lee","year":"2019","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbcan.2025.189457_bb0565","first-page":"13","article-title":"Increased neutrophil extracellular traps promote metastasis potential of hepatocellular carcinoma via provoking tumorous inflammatory response","author":"Yang","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bbcan.2025.189457_bb0570","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/path.5860","article-title":"Neutrophil extracellular traps drive epithelial-mesenchymal transition of human colon cancer","volume":"256","author":"Stehr","year":"2022","journal-title":"J. Pathol."},{"key":"10.1016\/j.bbcan.2025.189457_bb0575","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1093\/cvr\/cvab329","article-title":"Neutrophil extracellular traps: from physiology to pathology","volume":"118","author":"Hidalgo","year":"2022","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbcan.2025.189457_bb0580","doi-asserted-by":"crossref","first-page":"36","DOI":"10.21037\/tgh-24-8","article-title":"Involvement of interleukin-1\u03b2 in high glucose-activated proliferation of cholangiocarcinoma","volume":"9","author":"Khawkhiaw","year":"2024","journal-title":"Transl. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbcan.2025.189457_bb0585","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.3390\/cancers12082215","article-title":"Role of chemokines in the biology of cholangiocarcinoma","volume":"12","author":"Caligiuri","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2025.189457_bb0590","doi-asserted-by":"crossref","first-page":"6571","DOI":"10.7150\/jca.48327","article-title":"High level of interleukin-33 in cancer cells and cancer-associated fibroblasts correlates with good prognosis and suppressed migration in cholangiocarcinoma","volume":"11","author":"Yangngam","year":"2020","journal-title":"J. Cancer"},{"key":"10.1016\/j.bbcan.2025.189457_bb0595","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.immuni.2020.03.001","article-title":"CXCR1 and CXCR2 chemokine receptor agonists produced by tumors induce neutrophil extracellular traps that interfere with immune cytotoxicity","volume":"52","author":"Teijeira","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.bbcan.2025.189457_bb0600","first-page":"120","article-title":"Collagen-induced DDR1 upregulates CXCL5 to promote neutrophil extracellular traps formation and Treg infiltration in breast cancer","author":"Li","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bbcan.2025.189457_bb0605","first-page":"14","article-title":"Neutrophil extracellular traps in tumor progression and immunotherapy","author":"Yan","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2025.189457_bb0610","first-page":"8","article-title":"Interleukin-1\u03b2 mediates arterial Thrombus formation via NET-associated tissue factor","author":"Liberale","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.bbcan.2025.189457_bb0615","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190354","article-title":"Interleukin-17\u2013induced neutrophil extracellular traps mediate resistance to checkpoint blockade in pancreatic cancer","volume":"217","author":"Zhang","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbcan.2025.189457_bb0620","first-page":"6","article-title":"IL-33-induced neutrophil extracellular traps degrade fibronectin in a murine model of bronchopulmonary dysplasia","author":"Jin","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2025.189457_bb0625","doi-asserted-by":"crossref","unstructured":"Yamamoto H, Nakanishi Y, Hirano S. ASO author reflections: impact of neutrophil extracellular traps on extrahepatic cholangiocarcinomas. Ann. Surg. Oncol. 1234;31:1272\u20133. Doi: https:\/\/doi.org\/10.1245\/s10434-023-14772-x.","DOI":"10.1245\/s10434-023-14772-x"},{"key":"10.1016\/j.bbcan.2025.189457_bb0630","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216260","article-title":"Dual antiplatelet therapy inhibits neutrophil extracellular traps to reduce liver micrometastases of intrahepatic cholangiocarcinoma","volume":"567","author":"Yoshimoto","year":"2023","journal-title":"Cancer Lett."},{"issue":"Suppl. 3","key":"10.1016\/j.bbcan.2025.189457_bb0635","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1245\/s10434-015-4782-y","article-title":"Prognostic impact of Peritumoral IL-17-positive cells and IL-17 Axis in patients with intrahepatic cholangiocarcinoma","volume":"22","author":"Asukai","year":"2015","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.bbcan.2025.189457_bb0640","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1172\/JCI200318882","article-title":"Selectin-mucin interactions as a probable molecular explanation for the association of trousseau syndrome with mucinous adenocarcinomas","volume":"112","author":"Wahrenbrock","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2025.189457_bb0645","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/nrgastro.2013.120","article-title":"Mucins in pancreatic cancer and its microenvironment","volume":"10","author":"Kaur","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbcan.2025.189457_bb0650","doi-asserted-by":"crossref","DOI":"10.1016\/j.tru.2022.100123","article-title":"Tumour-associated Mucin1 correlates with the procoagulant properties of cancer cells of epithelial origin","volume":"9","author":"Chen","year":"2022","journal-title":"Thromb. Updat."},{"key":"10.1016\/j.bbcan.2025.189457_bb0655","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/S1470-2045(08)70277-8","article-title":"Clinical potential of mucins in diagnosis, prognosis, and therapy of ovarian cancer","volume":"9","author":"Singh","year":"2008","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbcan.2025.189457_bb0660","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/MCG.0000000000001050","article-title":"Mucin expression in colorectal Cancer (CRC): systematic review and Meta-analysis","volume":"53","author":"Niv","year":"2019","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.bbcan.2025.189457_bb0665","first-page":"928","article-title":"Characterization of the major sialyl-Lex-positive mucins present in colon, colon carcinoma, and sera of patients with colorectal cancer","volume":"55","author":"Hanski","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2025.189457_bb0670","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.prp.2010.08.004","article-title":"The expression of MUC mucin in cholangiocarcinoma","volume":"206","author":"Mall","year":"2010","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.bbcan.2025.189457_bb0675","doi-asserted-by":"crossref","first-page":"333","DOI":"10.21037\/atm.2018.07.16","article-title":"Current and future roles of mucins in cholangiocarcinoma\u2014recent evidences for a possible interplay with bile acids","volume":"6","author":"Danese","year":"2018","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.bbcan.2025.189457_bb0680","first-page":"117","article-title":"MUC1-C Oncoprotein integrates a program of EMT, epigenetic reprogramming and immune evasion in human carcinomas","volume":"1868","author":"Rajabi","year":"2017","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbcan.2025.189457_bb0685","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1161\/ATVBAHA.108.182188","article-title":"Biomarkers and venous thromboembolism","volume":"29","author":"Pabinger","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbcan.2025.189457_bb0690","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.3324\/haematol.2011.054718","article-title":"High D-dimer levels are associated with poor prognosis in cancer patients","volume":"97","author":"Ay","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.bbcan.2025.189457_bb0695","doi-asserted-by":"crossref","first-page":"192","DOI":"10.21037\/atm.2020.01.72","article-title":"The combination of preoperative D-dimer and CA19-9 predicts lymph node metastasis and survival in intrahepatic cholangiocarcinoma patients after curative resection","volume":"8","author":"Chen","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.bbcan.2025.189457_bb0700","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/3413969","article-title":"Clinical significance of prothrombin time in cholangiocarcinoma patients with surgeries","volume":"2019","author":"Wang","year":"2019","journal-title":"Can. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbcan.2025.189457_bb0705","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-021-08684-w","article-title":"Comprehensive analysis of coagulation indices for predicting survival in patients with biliary tract cancer","volume":"21","author":"Ke","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbcan.2025.189457_bb0710","doi-asserted-by":"crossref","first-page":"840","DOI":"10.3390\/ijms21030840","article-title":"MicroRNAs and neutrophil activation markers predict venous thrombosis in pancreatic ductal adenocarcinoma and distal extrahepatic cholangiocarcinoma","volume":"21","author":"Oto","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2025.189457_bb0715","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1177\/1076029611427900","article-title":"Hemostatic abnormalities in cirrhosis and tumor-related portal vein thrombosis","volume":"18","author":"Alkim","year":"2012","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"10.1016\/j.bbcan.2025.189457_bb0720","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.canlet.2005.03.059","article-title":"CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma","volume":"235","author":"Su","year":"2006","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2025.189457_bb0725","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.3390\/ijms21061920","article-title":"From classical laboratory parameters to novel biomarkers for the diagnosis of venous thrombosis","volume":"21","author":"Anghel","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2025.189457_bb0730","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jhep.2023.02.027","article-title":"Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinoma","volume":"79","author":"Lapitz","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbcan.2025.189457_bb0735","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S0168-8278(02)00239-8","article-title":"Platelet function rather than plasmatic coagulation explains hypercoagulable state in cholestatic liver disease","volume":"37","author":"Pihusch","year":"2002","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbcan.2025.189457_bb0740","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1097\/MCG.0b013e3181ce5b36","article-title":"Effect of preoperative biliary drainage on coagulation and fibrinolysis in severe obstructive cholestasis","volume":"44","author":"Kloek","year":"2010","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.bbcan.2025.189457_bb0745","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1016\/S1470-2045(22)00160-7","article-title":"2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19","volume":"23","author":"Farge","year":"2022","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbcan.2025.189457_bb0750","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1182\/bloodadvances.2020003442","article-title":"American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer","volume":"5","author":"Lyman","year":"2021","journal-title":"Blood Adv."},{"key":"10.1016\/j.bbcan.2025.189457_bb0755","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.3390\/cancers12051144","article-title":"Direct oral anticoagulants in cancer patients. Time for a change in paradigm","volume":"12","author":"Wojtukiewicz","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2025.189457_bb0760","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12959-022-00399-7","article-title":"Direct oral anticoagulants versus low-molecular-weight heparins for the treatment of acute venous thromboembolism in patients with gastrointestinal cancer: a systematic review and meta-analysis","volume":"20","author":"Rungjirajittranon","year":"2022","journal-title":"Thromb. J."},{"key":"10.1016\/j.bbcan.2025.189457_bb0765","first-page":"98","article-title":"Recurrent ischemic strokes in biliary tract malignancy: role of direct-acting oral anticoagulants and early screening \u2013 case series (P3-10.002)","author":"Mahmoud","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.bbcan.2025.189457_bb0770","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1814468","article-title":"Apixaban to prevent venous thromboembolism in patients with cancer","volume":"380","author":"Carrier","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbcan.2025.189457_bb0775","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1056\/NEJMoa1814630","article-title":"Rivaroxaban for Thromboprophylaxis in high-risk ambulatory patients with Cancer","volume":"380","author":"Khorana","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbcan.2025.189457_bb0780","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1055\/s-0040-1718927","article-title":"Venous thromboembolism in Cancer patients undergoing chemotherapy: risk factors and prevention","volume":"47","author":"Prandoni","year":"2021","journal-title":"Semin. Thromb. Hemost."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X25001994?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X25001994?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T04:27:34Z","timestamp":1781065654000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X25001994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":156,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0304419X25001994"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2025.189457","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer-associated thrombosis in cholangiocarcinoma: Exploring a phenotype of tumor aggressiveness","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2025.189457","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"189457"}}